Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TDP-43 AGGREGATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | TDP-43 AGGREGATION |
Knowledge base pages for this entity
graph TD
TDP_43_AGGREGATION["TDP-43 AGGREGATION"]
TDP_43_AGGREGATION -->|"causes"| Neurodegeneration["Neurodegeneration"]
TDP_43_AGGREGATION -->|"contributes to"| Als_Pathology["Als Pathology"]
TDP_43_AGGREGATION -->|"contributes to"| Ftd_Pathology["Ftd Pathology"]
TDP_43_AGGREGATION -->|"mediates"| TDP_43_Loss_Of_Function["TDP-43 Loss Of Function"]
TDP_43_AGGREGATION -.biomarker for.-> Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
TDP_43_AGGREGATION -->|"interacts"| TDP_43_Mislocalization["TDP-43 Mislocalization"]
p38__MAPK_inhibition["p38alpha MAPK inhibition"] -->|"reduces"| TDP_43_AGGREGATION
oxidative_stress["oxidative stress"] -->|"promotes"| TDP_43_AGGREGATION
SUMO2_3_conjugation["SUMO2/3 conjugation"] -.protects against.-> TDP_43_AGGREGATION
TARDBP["TARDBP"] -->|"involved_in"| TDP_43_AGGREGATION
cAMP_PKA_Signaling["cAMP/PKA Signaling"] -->|"modulates"| TDP_43_AGGREGATION
Loss_Of_ASRGL1["Loss Of ASRGL1"] -->|"causes"| TDP_43_AGGREGATION
Oxidative_Stress["Oxidative Stress"] -->|"activates"| TDP_43_AGGREGATION
ASRGL1["ASRGL1"] -->|"inhibits"| TDP_43_AGGREGATION| Target | Relation | Type | Str |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.98 |
| Neurodegeneration | causes | phenotype | 0.95 |
| Als Pathology | contributes_to | phenotype | 0.93 |
| Ftd Pathology | contributes_to | phenotype | 0.93 |
| TDP-43 Loss Of Function | mediates | phenotype | 0.90 |
| Amyotrophic Lateral Sclerosis | biomarker_for | disease | 0.90 |
| TDP-43 Mislocalization | interacts_with | process | 0.85 |
| Neuronal Lipid Profile Alterations | correlates_with | mechanism | 0.75 |
| neuronal viability | inhibits | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| p38α MAPK inhibition | reduces | process | 1.00 |
| SUMO2/3 conjugation | protects_against | process | 1.00 |
| oxidative stress | promotes | process | 1.00 |
| TARDBP | involved_in | protein | 0.98 |
| cAMP/PKA Signaling | modulates | pathway | 0.95 |
| Loss Of ASRGL1 | causes | mechanism | 0.95 |
| C9orf72 repeat expansion | causes | gene | 0.90 |
| Phase Separation | contributes_to | process | 0.90 |
| Oxidative Stress | activates | process | 0.90 |
| ASRGL1 | inhibits | gene | 0.90 |
| Phosphatidylserine | promotes | compound | 0.88 |
| Cardiolipin | promotes | compound | 0.88 |
| TDP-43 S409/S410 Phosphorylation | associated_with | process | 0.85 |
| Autophagy-Lysosome Pathway | involved_in | pathway | 0.85 |
| Oxidative Stress | exacerbates | process | 0.85 |
| NUFIP2 | contributes_to | protein | 0.80 |
| oxidative stress | causes | process | 0.80 |
| misfolded PrP | induces | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||